GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Cash Flow from Investing

Beximco Pharmaceuticals (DHA:BXPHARMA) Cash Flow from Investing : BDT-1,176 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2024, Beximco Pharmaceuticals spent BDT389 Mil on purchasing property, plant, equipment. It gained BDT20 Mil from selling property, plant, and equipment. It spent BDT0 Mil on purchasing business. It gained BDT0 Mil from selling business. It spent BDT0 Mil on purchasing investments. It gained BDT0 Mil from selling investments. It paid BDT27Mil for net Intangibles purchase and sale. And it received BDT51 Mil from other investing activities. In all, Beximco Pharmaceuticals spent BDT344 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2024.


Beximco Pharmaceuticals Cash Flow from Investing Historical Data

The historical data trend for Beximco Pharmaceuticals's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Cash Flow from Investing Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,510.00 -1,946.86 -2,524.65 -7,680.05 -2,617.02

Beximco Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -680.85 -474.56 -831.33 - -344.37

Beximco Pharmaceuticals Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Beximco Pharmaceuticals's Cash Flow from Investing for the fiscal year that ended in Jun. 2023 is calculated as:

Beximco Pharmaceuticals's Cash Flow from Investing for the quarter that ended in Mar. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-1,176 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beximco Pharmaceuticals  (DHA:BXPHARMA) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Beximco Pharmaceuticals's purchase of property, plant, equipment for the three months ended in Mar. 2024 was BDT-389 Mil. It means Beximco Pharmaceuticals spent BDT389 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Beximco Pharmaceuticals's sale of property, plant, equipment for the three months ended in Mar. 2024 was BDT20 Mil. It means Beximco Pharmaceuticals gained BDT20 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Beximco Pharmaceuticals's purchase of business for the three months ended in Mar. 2024 was BDT0 Mil. It means Beximco Pharmaceuticals spent BDT0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Beximco Pharmaceuticals's sale of business for the three months ended in Mar. 2024 was BDT0 Mil. It means Beximco Pharmaceuticals gained BDT0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Beximco Pharmaceuticals's purchase of investment for the three months ended in Mar. 2024 was BDT0 Mil. It means Beximco Pharmaceuticals spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Beximco Pharmaceuticals's sale of investment for the three months ended in Mar. 2024 was BDT0 Mil. It means Beximco Pharmaceuticals gained BDT0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Beximco Pharmaceuticals's net Intangibles purchase and sale for the three months ended in Mar. 2024 was BDT-27 Mil. It means Beximco Pharmaceuticals paid BDT27 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Beximco Pharmaceuticals's cash from discontinued investing activities for the three months ended in Mar. 2024 was 0 Mil. It means Beximco Pharmaceuticals paid BDT0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Beximco Pharmaceuticals's cash from other investing activities for the three months ended in Mar. 2024 was BDT51 Mil. It means Beximco Pharmaceuticals received BDT51 Mil from other investing activities.


Beximco Pharmaceuticals Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines